# Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects

> **NCT05272683** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG3667
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT05272683
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-28
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-22
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05272683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05272683, "Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05272683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*